IL1B and atherosclerosis: This study aimed to investigate the anti-atherosclerosis effects of chronic (16 weeks) treatment with anakinra to block IL-1 activity in apolipoprotein E knockout (ApoE–/–) mice fed an atherogenic diet, and to explore its possible mechanisms of action.